Phyllodes tumors are a rare type of breast tumor that can keep coming back, even if it’s benign. Learn more about the causes, risk factors, symptoms, diagnosis, treatment, and outlook for ...

Phyllodes tumors of the breast are rare fibroepithelial neoplasms that pose challenges due to its rapid growth and recurrence. Unlike breast cancers that arises from ducts or glands, ...

Dr. Jay Brooks answers the question: 'What is a phyllodes tumor?' — -- Question: What is a phyllodes tumor? Answer: Phyllodes sarcoma, or phyllodes tumors, are unusual cancers of the breast ...

Phyllodes tumor is a type of benign (non-cancerous) tumor located in the breast gland. It often grows rapidly, does not cause ...

Growing in a “leaf-like” pattern, from which they acquired their name, phyllodes tumors (PTs) are fibroepithelial tumors of the breast. They may occur at any age, but occur primarily in women ...

Phyllodes tumors (PTs) are fibroepithelial tumors of the breast. These are rare, presenting clinically as painless lumps. They are primarily found in women between the fourth and sixth decades of ...

Phyllodes tumors are fibroepithelial breast tumors with a broad range of behavior. These tumors are histologically classified as benign, borderline, or malignant (), 19 with benign lesions behaving ...

Diagnosis Low-grade phyllodes tumor of the left seminal vesicle. Management Laparoscopic excision of the left seminal vesicle. Background A 43-year-old man presented with a 2-year history of ...

Primary seminal vesicle tumors are very rare; less than 100 cases have been reported in the English literature to date. Patients usually present with lower urinary tract symptoms or hematospermia ...

Facing a breast cancer diagnosis can be an overwhelming experience, filled with uncertainty and fear, but knowledge is a powerful tool. Here's a guide on the different types of breast cancer, shedding ...

Phyllodes tumors are listed in the National Institute of Health's genetic and rare diseases program. On the center's website, surgery is described as the primary treatment for these rare malignancies ...